Endo International Plc
(NASDAQ : ENDP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 0.62%25.0814.1%$147.57m
ICLRICON plc -1.55%251.952.8%$141.91m
HZNPHorizon Therapeutics Plc -0.17%86.425.4%$113.85m
BHCBausch Health Cos., Inc. 0.62%25.080.0%$107.94m
CTLTCatalent, Inc. 0.06%102.082.0%$107.71m
JAZZJazz Pharmaceuticals Plc -1.70%136.762.1%$87.59m
SAVACassava Sciences, Inc. -2.89%36.330.0%$85.54m
UTHRUnited Therapeutics Corp. 0.05%200.0613.9%$78.87m
ZGNXZogenix, Inc. -0.08%25.987.5%$77.91m
PRGOPerrigo Co. Plc -2.27%38.846.9%$49.22m
ARGXargenx SE -0.79%279.250.0%$48.42m
PCRXPacira Biosciences, Inc. -0.89%63.439.8%$28.67m
BRBRBellRing Brands, Inc. 0.29%24.330.0%$26.08m
IRWDIronwood Pharmaceuticals, Inc. 0.64%10.999.5%$22.81m
SAGESAGE Therapeutics, Inc. -1.57%38.217.6%$17.91m

Company Profile

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment conducts certain manufacturing, quality assurance, R&D and administration functions. The Generic Pharmaceuticals segment conducts certain manufacturing, distribution, quality assurance and administration functions, as well as certain R&D functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.